Halozyme

Ocrevus

Pharma

Roche doubles down with subcutaneous FDA nod for MS star Ocrevus

The day after Roche gained an FDA approval for its subcutaneous version of Tecentriq, it also scored with a U.S. nod for its injected Ocrevus.

Kevin Dunleavy Sep 13, 2024 1:50pm

A stethoscope and paper money

J&J can reduce Darzalex royalty payments, a tribunal voted

Apr 8, 2022 9:55am

Argenx

Argenx's subcutaneous efgartigimod matches IV sibling in phase 3

Mar 22, 2022 7:55am